The NeurologyLive® dementia and Alzheimer disease clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to the care of patients with dementia and similar diseases, including Lewy body dementia, frontotemporal dementia, Alzheimer disease, and more.
Check out some of NeurologyLive®'s featured content in the carousel below.
Clinicians Raise Concerns Over Lecanemab Following Patient Death Treated With tPA for Stroke
January 5th 2023In the phase 3 Clarity AD trial, a 65-year-old patient treated with lecanemab died because of multiple cerebral hemorrhages after undergoing tissue plasminogen activator therapy for ischemic stroke.
Creating Innovative Ways to Improve Alzheimer Disease Prevention: Miia Kivipelto, MD, PhD
January 4th 2023The professor of clinical geriatric epidemiology at Karolinska Institutet discussed strategies for lowering the risk of Alzheimer disease, and the new ways to approach prevention. [WATCH TIME: 4 minutes]
Investigation Report on Biogen’s Alzheimer Drug Aducanumab Finds Flaws in Review Process, Pricing
January 3rd 2023A recent congressional investigation report on Biogen’s aducanumab and the FDA’s approval process recommended Biogen to fulfill their responsibility for individuals who rely on their treatments.
Need for a Multifactoral Approach to Treat Alzheimer Disease: Nicolas Villain, MD
January 2nd 2023The cognitive and behavioral neurology fellow at Pitié-Salpêtrière Hospital in Paris, France, provided perspective on the reasons to not solely rely on anti-amyloid treatments to treat Alzheimer disease. [WATCH TIME: 3 minutes]
Improving Biomarker Selection and Treating the Underlying Pathology of Dementia With Lewy Bodies
December 19th 2022James Galvin, MD, MPH, director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine, provided insight on the unmet needs for dementia with Lewy bodies, and whether success in Alzheimer disease can help.